I

Immunome

Antibody-based therapeutic discovery and development

Senior Director, Pharmacometrics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeBothell, WA, USA$288k - $353.6kIn-person

About the Job

Requirements

  • A Ph.D. in Pharmacometrics, Clinical Pharmacology, Pharmaceutical Sciences, Statistics, Bioengineering, Applied Mathematics, or a related quantitative discipline with 12+ years of relevant biopharmaceutical industry experience; an M.S. with 15+ years; or a B.S. with 18+ years of relevant experience in clinical pharmacology, pharmacometrics, quantitative pharmacology, or related drug development functions, or equivalent experience.
  • A demonstrated track record leading pharmacometrics strategy and execution across multiple clinical-stage programs, including early development, late-stage development, and regulatory submission support.
  • Deep expertise in population pharmacokinetics, pharmacokinetics/pharmacodynamics, exposure-response, simulation, dose optimization, and model-informed drug development.
  • Experience supporting global regulatory filings and interactions, including IND, NDA, BLA, briefing book, labeling, and health authority response activities.
  • Hands-on experience with pharmacometrics and quantitative analysis tools such as NONMEM, Monolix, Phoenix, R, SAS, Python, MATLAB, Simcyp, GastroPlus, or related platforms.
  • Experience managing external pharmacometrics vendors, contract research organizations, consultants, and cross-functional deliverables.
  • Oncology drug development experience is required.
  • In-depth knowledge of clinical pharmacology, pharmacometrics, population pharmacokinetics, exposure-response, physiologically based pharmacokinetic modeling, quantitative systems pharmacology, translational modeling, and quantitative decision-making across drug development.
  • Strong understanding of global regulatory expectations for model-informed drug development, dose justification, labeling support, and submission-quality pharmacometrics documentation.
  • Proven leadership and project management skills across multiple programs, vendors, timelines, and stakeholders.
  • Demonstrated success influencing cross-functional teams and driving data-informed decisions in a matrixed biotech or pharmaceutical environment.

Responsibilities

  • Develop and implement pharmacometrics strategies across clinical development programs, ensuring quantitative approaches align with program objectives, clinical pharmacology plans, and regulatory expectations.
  • Serve as the pharmacometrics strategy lead for assigned programs, providing scientific leadership for dose selection, dose optimization, exposure-response assessment, and model-informed decision-making.
  • Contribute to the long-term vision for quantitative clinical pharmacology capabilities, including standards for modeling, simulation, documentation, and cross-functional integration.
  • Lead the development and execution of population pharmacokinetics, pharmacokinetics/pharmacodynamics, exposure-response, disease progression, and model-based meta-analysis strategies to support clinical development and registration.
  • Apply fit-for-purpose physiologically based pharmacokinetic modeling, quantitative systems pharmacology, translational modeling, or simulation approaches to inform first-in-human strategy, dose escalation, dose expansion, special populations, drug-drug interaction risk, and lifecycle development.
  • Oversee analysis plans, model development, simulations, quality control, and interpretation of pharmacometric outputs to ensure scientific rigor, reproducibility, and regulatory readiness.
  • Partner with Clinical Pharmacology, Clinical Development, Biostatistics, ADME, Translational Science, Bioanalytical, Regulatory, Clinical Operations, Data Management, and Medical Writing to integrate pharmacometrics deliverables into development plans and study timelines.
  • Provide input into clinical protocols, sparse and intensive pharmacokinetics/pharmacodynamics sampling strategies, statistical analysis plans, data standards, and integrated evidence generation plans.
  • Serve as the primary pharmacometrics representative on cross-functional program teams and governance forums, translating quantitative findings into clear development recommendations.
  • Author, review, and provide strategic oversight for pharmacometrics components of clinical pharmacology plans, modeling and simulation analysis plans, reports, investigator brochures, clinical study reports, and regulatory submissions.
  • Lead pharmacometrics contributions to INDs, NDAs, BLAs, briefing books, responses to health authority questions, and labeling discussions.
  • Ensure pharmacometrics activities align with applicable FDA, EMA, ICH, and global regulatory expectations for model-informed drug development, population pharmacokinetics, and exposure-response analyses.
  • Identify, qualify, and manage external pharmacometrics vendors, consultants, and contract research organization partners to ensure high-quality, timely, scientifically robust deliverables.
  • Maintain oversight of outsourced analyses, including scope definition, budget planning, timeline management, technical review, and quality control of modeling and simulation outputs.
  • Lead and mentor pharmacometricians and quantitative scientists, fostering scientific excellence, innovation, accountability, and collaboration.
  • Communicate complex modeling results and development implications clearly to senior leaders, cross-functional stakeholders, external collaborators, and regulatory audiences.
  • Collaborate with Clinical Pharmacology, Clinical Development, Regulatory, ADME, Bioanalytical, Translational Science, and Biometrics functions to align quantitative strategies with broader development objectives.

Desired Qualifications

  • Experience with antibody-drug conjugates, biologics, targeted radiotherapies, or small molecules is preferred.

About the Company

Immunome

Antibody-based therapeutic discovery and development

Immunome identifies antibodies and their targets by studying the immune systems of patients who recover from diseases, to develop first-in-class therapeutics. Its platform analyzes immune responses to discover novel antibodies and their targets, which are then advanced through research and development in partnership with healthcare and medical research clients. The company’s products work by using antibodies discovered from patients’ immune systems to target diseases, potentially enabling new treatments across oncology and other areas. Immunome differentiates itself through a proprietary discovery platform that extracts clinically relevant antibodies from real patient immune responses, enabling collaborations and licensing deals rather than solely pursuing standalone drug sales. The goal is to bring new antibody therapies to patients by forming partnerships, licensing innovations, and eventually delivering approved therapies.

Company size
201-500
Company stage
IPO
Headquarters
Bothell, WA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Immunome

See more jobs